About Blepharophimosis-ptosis-epicanthus inversus syndrome plus
Blepharophimosis-ptosis-epicanthus inversus syndrome plus is a rare disease catalogued by Orphanet (ORPHA:572333). It is associated with the FOXL2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Blepharophimosis-ptosis-epicanthus inversus syndrome plus trials.
Search ClinicalTrials.gov for "Blepharophimosis-ptosis-epicanthus inversus syndrome plus" or filter by Orphanet code ORPHA:572333 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Blepharophimosis-ptosis-epicanthus inversus syndrome plus trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Blepharophimosis-ptosis-epicanthus inversus syndrome plus. Updated daily.